Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Non-Hodgkin Lymphoma (Late Stage^), 2015-2019

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Name
State
 sort alphabetically by name descending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 12.1 (12.1, 12.2) N/A 45,944 64.0
Alabama 6 10.0 (9.6, 10.4) 45 (42, 48) 595 63.1
Alaska 6 11.0 (9.8, 12.2) 39 (17, 47) 79 61.9
Arizona 6 9.2 (8.9, 9.5) 49 (46, 49) 788 61.1
Arkansas 6 11.2 (10.7, 11.7) 37 (30, 43) 415 61.0
California 3 11.9 (11.8, 12.0) 32 (26, 36) 5,110 66.2
Colorado 6 11.8 (11.4, 12.2) 34 (24, 38) 711 69.0
Connecticut 3 13.4 (12.9, 13.9) 8 (3, 20) 613 63.4
Delaware 6 12.4 (11.5, 13.3) 25 (6, 39) 155 67.0
District of Columbia 6 9.3 (8.2, 10.4) 47 (40, 50) 62 63.5
Florida 6 11.4 (11.2, 11.6) 36 (33, 39) 3,259 50.2
Georgia 3 11.9 (11.6, 12.2) 33 (24, 36) 1,317 66.4
Hawaii 3 9.2 (8.6, 9.9) 48 (44, 49) 169 60.8
Idaho 3 13.1 (12.3, 13.8) 14 (3, 31) 258 68.1
Illinois 3 12.6 (12.3, 12.9) 21 (14, 28) 1,873 65.5
Indiana 6 12.5 (12.2, 12.9) 22 (12, 31) 974 68.7
Iowa 3 14.7 (14.2, 15.3) 2 (1, 5) 566 69.2
Kansas 6 12.9 (12.3, 13.4) 17 (6, 30) 435 67.4
Kentucky 3 13.5 (13.1, 14.0) 7 (3, 18) 727 69.3
Louisiana 3 12.3 (11.8, 12.7) 26 (15, 35) 656 65.7
Maine 6 14.2 (13.4, 15.0) 3 (1, 16) 272 69.6
Maryland 6 12.2 (11.8, 12.6) 28 (18, 35) 857 68.7
Massachusetts 3 12.7 (12.4, 13.1) 18 (10, 28) 1,064 67.0
Michigan 6 13.0 (12.7, 13.3) 15 (7, 22) 1,606 66.9
Minnesota 6 14.1 (13.7, 14.5) 4 (1, 10) 929 66.0
Mississippi 6 10.7 (10.2, 11.2) 42 (36, 46) 369 63.3
Missouri 6 12.6 (12.3, 13.0) 20 (12, 29) 950 68.6
Montana 6 11.7 (10.8, 12.5) 35 (16, 43) 161 65.9
Nebraska 6 13.2 (12.5, 13.9) 11 (3, 28) 295 65.6
New Hampshire 6 12.9 (12.2, 13.7) 16 (4, 34) 229 61.9
New Jersey 3 13.3 (13.0, 13.6) 9 (5, 18) 1,427 60.6
New Mexico 3 7.8 (7.3, 8.3) 50 (49, 50) 200 53.4
New York 3 13.1 (12.9, 13.3) 13 (7, 19) 3,101 61.2
North Carolina 6 12.2 (11.9, 12.5) 29 (20, 34) 1,485 68.7
North Dakota 6 12.5 (11.5, 13.7) 23 (3, 40) 108 68.4
Ohio 6 13.3 (13.0, 13.5) 10 (6, 18) 1,916 68.8
Oklahoma 6 11.1 (10.7, 11.6) 38 (33, 43) 507 64.1
Oregon 6 11.9 (11.5, 12.4) 31 (20, 37) 612 65.5
Pennsylvania 6 13.8 (13.5, 14.1) 6 (3, 10) 2,301 67.9
Puerto Rico 6 6.3 (5.9, 6.6) N/A 247 42.9
Rhode Island 6 12.2 (11.4, 13.1) 27 (7, 40) 161 63.7
South Carolina 6 10.2 (9.8, 10.6) 43 (40, 47) 631 63.3
South Dakota 6 13.2 (12.2, 14.3) 12 (2, 34) 138 70.4
Tennessee 6 10.9 (10.6, 11.3) 40 (36, 43) 885 61.9
Texas 3 10.2 (10.0, 10.3) 44 (42, 47) 2,840 58.7
Utah 3 12.5 (11.9, 13.1) 24 (9, 35) 339 68.7
Vermont 6 12.6 (11.6, 13.8) 19 (3, 39) 108 66.8
Virginia 6 10.8 (10.5, 11.1) 41 (36, 43) 1,060 65.3
Washington 5 12.1 (11.8, 12.5) 30 (19, 35) 1,035 63.2
West Virginia 6 13.9 (13.2, 14.6) 5 (1, 17) 346 69.6
Wisconsin 6 14.8 (14.4, 15.2) 1 (1, 4) 1,061 70.3
Wyoming 6 9.9 (8.9, 11.1) 46 (34, 49) 67 58.6
Nevada 6
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 12/03/2022 11:45 am.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Nevada

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top